8-K
Current Report
Actinium Pharmaceuticals, Inc. Filed Acc 0001213900-13-002945
Agreement ended · Executive or director change
- Item 1.02 Termination of a material definitive agreement
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading f8k053113_actinium.htm…